Literature DB >> 25856665

PET imaging with the non-pure positron emitters: (55)Co, (86)Y and (124)I.

P E N Braad1, S B Hansen, H Thisgaard, P F Høilund-Carlsen.   

Abstract

PET/CT with non-pure positron emitters is a highly valuable tool in immuno-PET and for pretherapeutic dosimetry. However, imaging is complicated by prompt gamma coincidences (PGCs) that add an undesired background activity to the images. Time-of-flight (TOF) reconstruction improves lesion detectability in (18)F-PET and can potentially also improve the signal-to-noise ratio in images acquired with non-pure positron emitters. Using the GE Discovery 690 PET/CT system, we evaluated the image quality with (55)Co, (86)Y and (124)I, and the effect of PGC-correction and TOF-reconstruction on image quality and quantitation in a series of phantom studies. PET image quality and quantitation for all isotopes were significantly affected by PGCs. The effect was most severe with (86)Y, and less, but comparable, with (55)Co and (124)I. PGC-correction improved the image quality and the quantitation accuracy dramatically for all isotopes, especially when the activity was limited to a few hot lesions in a warm background. In imaging situations, where high levels of activity were present in the background, activity concentrations were overestimated. TOF-reconstruction improved image quality in isolated lesions but worsened the accuracy of quantitation and uniformity in homogeneous activity distributions. Better modelling of PGCs in the scatter correction can potentially improve the situation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25856665     DOI: 10.1088/0031-9155/60/9/3479

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  8 in total

1.  A PSMA Ligand Labeled with Cobalt-55 for PET Imaging of Prostate Cancer.

Authors:  Johan Hygum Dam; Birgitte Brinkmann Olsen; Christina Baun; Poul Flemming Høilund-Carlsen; Helge Thisgaard
Journal:  Mol Imaging Biol       Date:  2017-12       Impact factor: 3.488

Review 2.  Non-invasive radionuclide imaging of trace metal trafficking in health and disease: "PET metallomics".

Authors:  George Firth; Julia E Blower; Joanna J Bartnicka; Aishwarya Mishra; Aidan M Michaels; Alex Rigby; Afnan Darwesh; Fahad Al-Salemee; Philip J Blower
Journal:  RSC Chem Biol       Date:  2022-04-11

3.  In Vivo Evaluation of a Bombesin Analogue Labeled with Ga-68 and Co-55/57.

Authors:  Johan Hygum Dam; Birgitte Brinkmann Olsen; Christina Baun; Poul-Flemming Høilund-Carlsen; Helge Thisgaard
Journal:  Mol Imaging Biol       Date:  2016-06       Impact factor: 3.488

4.  Yttrium-86 Is a Positron Emitting Surrogate of Gadolinium for Noninvasive Quantification of Whole-Body Distribution of Gadolinium-Based Contrast Agents.

Authors:  Mariane Le Fur; Nicholas J Rotile; Carlos Correcher; Veronica Clavijo Jordan; Alana W Ross; Ciprian Catana; Peter Caravan
Journal:  Angew Chem Int Ed Engl       Date:  2019-12-04       Impact factor: 15.336

5.  Improving Contrast and Detectability: Imaging with [55Co]Co-DOTATATE in Comparison with [64Cu]Cu-DOTATATE and [68Ga]Ga-DOTATATE.

Authors:  Thomas L Andersen; Christina Baun; Birgitte B Olsen; Johan H Dam; Helge Thisgaard
Journal:  J Nucl Med       Date:  2019-09-13       Impact factor: 10.057

6.  High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26.

Authors:  Bogdan Mitran; Helge Thisgaard; Ulrika Rosenström; Johan Hygum Dam; Mats Larhed; Vladimir Tolmachev; Anna Orlova
Journal:  Contrast Media Mol Imaging       Date:  2017-08-10       Impact factor: 3.161

7.  The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule.

Authors:  Javad Garousi; Ken G Andersson; Johan H Dam; Birgitte B Olsen; Bogdan Mitran; Anna Orlova; Jos Buijs; Stefan Ståhl; John Löfblom; Helge Thisgaard; Vladimir Tolmachev
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

Review 8.  Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs.

Authors:  Cassandra Miller; Julie Rousseau; Caterina F Ramogida; Anna Celler; Arman Rahmim; Carlos F Uribe
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.